Results: Ibiden Co.,Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Shareholders of Ibiden Co.,Ltd. (TSE:4062) will be pleased this week, given that the stock price is up 18% to JP¥4,824 following its latest annual results. Revenues were JP¥369b, approximately in line with expectations, although statutory earnings per share (EPS) performed substantially better. EPS of JP¥241 were also better than expected, beating analyst predictions by 18%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Taking into account the latest results, the current consensus from IbidenLtd's 15 analysts is for revenues of JP¥408.1b in 2026. This would reflect a meaningful 10% increase on its revenue over the past 12 months. Statutory per share are forecast to be JP¥240, approximately in line with the last 12 months. Yet prior to the latest earnings, the analysts had been anticipated revenues of JP¥413.4b and earnings per share (EPS) of JP¥243 in 2026. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.

View our latest analysis for IbidenLtd

The analysts reconfirmed their price target of JP¥5,628, showing that the business is executing well and in line with expectations. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values IbidenLtd at JP¥7,200 per share, while the most bearish prices it at JP¥4,300. There are definitely some different views on the stock, but the range of estimates is not wide enough as to imply that the situation is unforecastable, in our view.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. It's clear from the latest estimates that IbidenLtd's rate of growth is expected to accelerate meaningfully, with the forecast 10% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 4.2% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 6.3% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect IbidenLtd to grow faster than the wider industry.

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for IbidenLtd going out to 2028, and you can see them free on our platform here.

Plus, you should also learn about the 2 warning signs we've spotted with IbidenLtd .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.